The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Metabolomics in hypertension
Open accessAbstract
Hypertension is the most prevalent chronic medical condition and a major risk factor for cardiovascular morbidity and mortality. In the majority of hypertensive cases, the underlying cause of hypertension cannot be easily identified because of the heterogeneous, polygenic and multi-factorial nature of hypertension. Metabolomics is a relatively new field of research that has been used to evaluate metabolic perturbations associated with disease, identify disease biomarkers and to both assess and predict drug safety and efficacy. Metabolomics has been increasingly used to characterize risk factors for cardiovascular disease, including hypertension, and it appears to have significant potential for uncovering mechanisms of this complex disease. This review details the analytical techniques, pre-analytical steps and study designs used in metabolomics studies, as well as the emerging role for metabolomics in gaining mechanistic insights into the development of hypertension. Suggestions as to the future direction for metabolomics research in the field of hypertension are also proposed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, metabolomics studies of hypertension are limited, but changes in lipid and fatty acid profiles have been reported229.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [229]
Citations
Cites
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl254 · Cited by 6,077
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
HMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,219
HMDB 3.0—The Human Metabolome Database in 2013
Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., Djoumbou-Feunang, Y., Mandal, R., Aziat, F., Dong, E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1065 · Cited by 2,845
World Health Organization, I. S. O. H. W. G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,667
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,269
Psychogios, N., Hau, D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., Sinelnikov, I. V., Krishnamurthy, R., Eisner, R., Gautam, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016957 · Cited by 1,779
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.3.329 · Cited by 1,155
Research works printed but not linked: 4
- Griffin, 2006, The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball Phil Trans R Soc Lond B Biol S, ci, 361, 147
- 1994, 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)., Lancet, 344, 1383
- Boos, 2006, Is hypertension an inflammatory process Curr Pharm D, es, 12, 1623
- 2000, Am J Obstet G, ynecol, 183, S1
Cited by
Sorted by citations
Olsen, M. H., Angell, S. Y., Asma, S., Boutouyrie, P., Burger, D. E., Chirinos, J. A., Damasceno, A. A. M., Delles, C., Gimenez‐Roqueplo, A., Hering, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31134-5 · Cited by 970
Self-citationThe gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
Yang, T., Richards, E. M., Pepine, C. J., & Raizada, M. K. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0018-2 · Cited by 753
Wang, L., Hou, E., Wang, L., Wang, Y., Yang, L., Zheng, X., Xie, G., Sun, Q., Liang, M., & Tian, Z. (2014) · Analytica Chimica Acta · doi:10.1016/j.aca.2014.11.009 · Cited by 95
Metabolomics of mitochondrial disease
Esterhuizen, K., van der Westhuizen, F. H., & Louw, R. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.05.012 · Cited by 94
Metabolomic characterization of hypertension and dyslipidemia
Ke, C., Zhu, X., Zhang, Y., & Shen, Y. (2018) · Metabolomics · doi:10.1007/s11306-018-1408-y · Cited by 97
Metadata
- Authors
- Nikolic, S. B., Sharman, J. E., Adams, M. J., & Edwards, L. M.
- Affiliations
- University of Tasmania (AU)
- King's College London (GB)
- Corresponding author
- Edwards, Lindsay M.
- Venue
- Journal of Hypertension
- Published
- 2014-06
- Volume
- 32
- Issue
- 6
- Pages
- 1159-1169
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2087492315
- Cited by
- 79
- References
- 85
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 7 · 2021: 12 · 2020: 8 · 2019: 1 · 2018: 12 · 2017: 6 · 2016: 8 · 2015: 3 · 2014: 3
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Murdoch University Research Portal (submittedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Keywords
- hypertension, metabolomics, cardiovascular risk factors, disease biomarkers, metabolic perturbation, hypertension pathogenesis, analytical methods
- MeSH terms
- Animals, Cardiovascular Diseases, Clinical Trials as Topic, Humans, Hypertension, Magnetic Resonance Spectroscopy, Risk Factors, Mass Spectrometry, Reproducibility of Results, Biomarkers, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolomics in hypertension. https://app.cochat.ai/papers/10.1097/hjh.0000000000000168
- The paper
- Nikolic, S. B., Sharman, J. E., Adams, M. J., & Edwards, L. M. (2014). Metabolomics in hypertension. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000000168
